Evaluation and management of hemoptysis in infants and children. A report of nine cases

Ann Otol Rhinol Laryngol. 1996 Jul;105(7):516-20. doi: 10.1177/000348949610500704.

Abstract

Hemoptysis is an occasional complication of adult pulmonary disease and is rare in children. The most common causes in adults are infection, bronchiectasis, pulmonary neoplasm, cystic fibrosis, pulmonary infarct, and trauma; in children the most common causes are infection and congenital abnormalities of the cardiopulmonary vasculature. Nine cases of hemoptysis in seven infants and two children will be presented. Two cases were fatal, thus illustrating the importance of rapid and definitive therapy early in the course. One of the fatal cases is the first case report in the otolaryngological literature of fatal hemoptysis in the newborn as a result of vascular anomalies associated with an absent left pulmonary artery. Eight cases of various causes, including small vessel vascular abnormality, trauma, recurrent pulmonary infection, and laryngotracheal papilloma, are discussed. The literature is reviewed, embryology is discussed, and a mechanism of death is theorized for the patient with the congenital vessel anomaly. Management considerations for hemoptysis in infants and children are discussed.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Bronchoalveolar Lavage
  • Bronchoscopy
  • Cefuroxime / therapeutic use*
  • Child
  • Child, Preschool
  • Chlamydia trachomatis / isolation & purification
  • Female
  • Hemoptysis / diagnosis
  • Hemoptysis / drug therapy*
  • Hemoptysis / microbiology
  • Humans
  • Infant
  • Lung / microbiology
  • Male
  • Mydriatics / therapeutic use*
  • Phenylephrine / therapeutic use*
  • Pneumocystis / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Mydriatics
  • Phenylephrine
  • Cefuroxime